Agrace Offers New ‘Learning to Live with Dementia’ Education Series

MADISON, Wis. — Agrace knows that caring for a loved one with dementia can be both rewarding and challenging, and that caregivers often find themselves searching for guidance and help. To support any person providing care or navigating this journey, Agrace is offering Learning to Live with Dementia,a comprehensive education series.

The Learning to Live with Dementia education series consists of eight classes taught by experienced Agrace staff who have experience caring for people with dementia and by experts from the community. These sessions provide valuable insights into the unique needs of individuals living with dementia and offer caregivers a space to learn, ask questions and connect with others who share similar experiences.

Classes are $20 each and take place at Agrace, 5395 E. Cheryl Parkway, Fitchburg, or online using Microsoft Teams. In July, Agrace is offering these classes:

• “Legal and Financial Decisions” – July 1, 11 a.m.
• “Facility Support when You Need It” – July 17, 12 p.m.
• “Living at Home with Dementia” – July 26, 12 p.m.

Whether you’re new to caregiving or have been supporting a loved one for years, these classes will help you navigate legal and financial planning, options for facility care and strategies to help individuals who are living alone with dementia. You do not need to be receiving Agrace services to attend—these classes are open to any caregiver looking for guidance and support.

Attend all eight classes for $100 or register for an individual class for $20. To register, visit Agrace.org/Dementia. For questions, contact DementiaSupport@Agrace.org or call (608) 276-4660.

Founded in 1978, Agrace is a nonprofit, community-supported health care organization dedicated to providing high-quality care and support to people who are aging, seriously ill, dying or grieving. With offices in Madison, Wauwatosa, Watertown, Janesville, Baraboo and Dodgeville, Agrace serves more than 1,700 patients and clients across southern Wisconsin every day.

RMHC-Madison and Rogers Behavioral Health Collaborate to Bring Home-Like Support to Families’ Health Journey

RMHC-Madison and Rogers Behavioral Health Collaborate to Bring Home-Like Support to Families’ Health Journey 

Madison, WI — Ronald McDonald House Charities of Madison and Rogers Behavioral Health are proud to announce a new collaboration that will provide daytime access to the Ronald McDonald House for families whose children are receiving treatment at Rogers’ Madison clinic.

This collaboration expands RMHC-Madison’s mission of keeping families close by offering a welcoming and supportive environment for caregivers and siblings during the day while their child is receiving mental health treatment. Families can now enjoy a restful space filled with the comforts of home, including access to nourishing meals, laundry facilities, play areas for siblings and quiet spaces to recharge while their child is in care.

“We are thrilled to welcome Rogers families into our House during the day,” said Stephanie Hayden, CEO of RMHC-Madison. “Navigating a child’s health journey, either physical or mental, can be overwhelming. The collaboration reflects a shared commitment by both organizations to support the whole family during a child’s medical journey — recognizing that healing happens best when families are cared for, too.”

Day-use families will be welcomed by RMHC-Madison’s caring staff and volunteers and have full access to the House’s communal amenities from morning through late afternoon. This service is offered at no cost to families thanks to the generosity of RMHC-Madison donors and partners.

“At Rogers, we believe in the power of family involvement in the healing process,” said Cindy Meyer, president and CEO of Rogers Behavioral Health. “This collaboration with RMHC-Madison helps ease the emotional and practical burdens on parents and caregivers while their children receive vital treatment. Having a space to rest and recharge makes a meaningful difference in the whole family’s recovery journey.”

For more information on how RMHC-Madison strengthens families and promotes healing, please visit rmhcmadison.org. For more information on Rogers’ life-saving services, visit rogersbh.org.

###

About Ronald McDonald House Charities of Madison: Since 1993, Ronald McDonald House Charities of Madison has provided a continuum of care for those who live hours or even a plane ride from their child’s treatment. By offering housing, meals and a supportive community, RMHC-Madison is Keeping Families Close during life’s most challenging moments.

Through the Ronald McDonald House® and the Ronald McDonald Family Room® at SSM Health St. Mary’s Hospital, families can stay close during life’s most challenging moments and receive the care they need.

About Rogers Behavioral Health
Rogers Behavioral Health is a nationally recognized not-for-profit provider of mental health and addiction services. Rogers offers evidence-based treatment for adults, children and adolescents with depression and other mood disorders, eating disorders, addiction, OCD, anxiety disorders, trauma and PTSD. In addition to locations in California, Colorado, Florida, Georgia, Illinois, Minnesota, Pennsylvania, Tennessee and Washington, Rogers operates three inpatient behavioral health hospitals, 17 residential programs and nine centers offering PHP and IOP treatment in Wisconsin. Outpatient services for medication management and psychiatric evaluations are offered virtually and in-person in Wisconsin.

The System also includes the Ladish Co. Foundation Center, home to Rogers Research Center and the Ronald McDonald Family Room®. In addition, Rogers leads the nationwide WISE coalition with the goal of eliminating stigma related to mental health and substance use disorders. Learn more at rogersbh.org.

Exact Sciences to Highlight Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

MADISON, Wis. – Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it will present ten abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30–June 3, 2025, in Chicago, Ill. Presentations include new data on the Oncodetect™ molecular residual disease (MRD) test, multi-cancer early detection (MCED) testing, the Oncotype DX Breast Recurrence Score^® test, and the Cologuard^® test that underscore Exact Sciences’ expanding portfolio and commitment to advancing care through scientific excellence.

“The data Exact Sciences will present at ASCO 2025 reflect the scientific rigor and clinical significance of our expanding portfolio and pipeline,” said Dr. Rick Baehner, MD, chief medical officer, Precision Oncology at Exact Sciences. “From MRD to MCED to CRC screening, we are advancing evidence-based innovations that help empower providers and deliver crucial answers to patients. Every study, partnership, and data point move us closer to a future where cancer is detected earlier and treated with greater precision.”

Real-world evidence supporting the Cologuard test continues to grow, with ongoing research into repeat screening. New data from prominent experts and research groups reinforce the Oncotype DX^® test as a trusted, evidence-backed tool, further affirming its role as the standard of care for predicting chemotherapy benefit for breast cancer patients. Building on more than a decade of experience with Cologuard and 20 years of leadership with the Oncotype DX test, Exact Sciences continues to advance the future of precision oncology and multi-cancer screening.

New Data and Continuous Evidence Generation Underscore the Oncodetect Test’s Power to Detect Cancer Recurrence. Data from the Beta-CORRECT study further strengthens the clinical foundation of the Oncodetect test, confirming its role in helping guide treatment decisions and surveillance strategies for patients with stage II–IV colorectal cancer¹. Expanding on this evidence to multiple solid tumor types, Exact Sciences and Flatiron Health continue enrollment in a multi-year, prospective study evaluating how MRD testing can improve cancer monitoring and treatment decisions in community care settings.

New Data Support Promise of MCED as Exact Sciences Prepares for LDT Launch. A modeling study found annual MCED testing could reduce late-stage cancer incidence by more than 40% and mortality by up to 18% in high-risk groups². Additionally, the Falcon registry, a large, prospective real-world study of Exact Sciences’ MCED test, will track 25,000 participants against a 50,000-person standard-care cohort to assess adoption, outcomes, and patient experience. These findings come as Exact Sciences prepares to launch Cancerguard™ EX, its MCED lab-developed test (LDT), in the second half of the year, marking a significant step in expanding access to earlier cancer detection.

Exact Sciences abstracts at ASCO include:

Precision Oncology

• The Association of Circulating Tumor DNA (ctDNA) with Recurrence in Patients with Stage II-IV Colorectal Cancer: The ꞵ-CORRECT Study
  • Saturday, May 31, 2025, from 9:00 AM to 12:00 PM CT
  • Abstract number: 3590
• Molecular Residual Disease (MRD) in Solid Tumors
  • Monday, June 2, 2025, from 9:00 AM to 12:00 PM CT
  • Abstract number: TPS3186
• Enhancing Recurrence Detection in Stage III Colorectal Cancer Patients Through Molecular Residual Disease Test-guided Surveillance: A Modeling Study
  • Abstract number: e15600
• Patient outcomes in WSG-ADAPT according to NATALEE and MonarchE risk criteria
  • Monday, June 2, 2025, from 9:00 AM to 12:00 PM CT
  • Abstract number: 601

Screening

• Adherence to repeat screening for colorectal cancer using the multi-target stool DNA test: Real-world analysis of patients from Federally Qualified Health Centers
  • Saturday, May 31, 2025, from 9:00 AM to 12:00 PM CT
  • Abstract number: 3630
• A decade of progress: Trends in 5-year survival across 17 cancer types
  • Abstract number: e23262
• The potential of multi-cancer early detection screening in reducing cancer incidence and mortality in high-risk groups: A modeling study
  • Saturday, May 31, 2025, from 1:30 PM to 5:30 PM CT
  • Abstract number: 10542
• Falcon – Exact Sciences’ multi-cancer early detection (MCED) real-world evidence (RWE) registry
  • Saturday, May 31, 2025, from 1:30 PM to 5:30 PM CT
  • Abstract number: TPS11189
• Evaluation of plasma methylated DNA markers for detection HPV-positive oropharyngeal squamous cell carcinoma: a case control study
  • Monday, June 2, 2025, from 9:00 AM to 12:00 PM CT
  • Abstract number: 6057
• Feasibility of vaginal tampons versus vaginal swabs in the collection of vaginal fluid for endometrial cancer testing
  • Abstract number: e17617

References

1.  Hashimoto et al. The association of ctDNA with recurrence in patients with stage II-IV colorectal cancer: The β-CORRECT study. Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025.

2.  Chhatwal, J., Xiao, J., ElHabr, A., Tyson, C., Cao, X., Raoof, S., Fendrick, A. M., Ozbay, A. B., Limburg, P., Beer, T. M., Deshmukh, A., & Briggs, A. (2025). The potential of multi-cancer early detection screening in reducing cancer incidence and mortality in high-risk groups: A modeling study. Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025

About Exact Sciences Corp. 

A leading provider of cancer screening and diagnostic tests, Exact Sciences helps give patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard^® and Oncotype DX^® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

NOTE: Oncotype DX Breast Recurrence Score and Oncodetect are trademarks of Genomic Health, Inc., a wholly owned subsidiary of Exact Sciences. Exact Sciences, Cologuard, and Cancerguard are trademarks of Exact Sciences.

Vierbicher Again Recognized as a Top Firm to Work For

Vierbicher Honored Again with Zweig Group’s 2025 Best Firms to Work For and Hot Firm Awards

REEDSBURG, WI – Vierbicher, a trusted leader in engineering, planning and surveying, is proud to announce that it has once again been recognized by the Zweig Group with two of the industry’s most distinguished honors: the 2025 Best Firms to Work For Award and the 2025 Hot Firm Award.

This marks the third time Vierbicher has earned the Best Firms to Work For recognition and the second time being named a Hot Firm — an affirmation of the company’s ongoing commitment to creating an outstanding workplace culture and driving strategic growth.

The Best Firms to Work For Award highlights architecture, engineering and construction (AEC) firms that prioritize employee experience, professional development and workplace satisfaction. Vierbicher’s people-first culture, strong values and collaborative approach continue to set it apart.

The Hot Firm Award celebrates the 100 fastest-growing AEC firms in the United States and Canada. Vierbicher’s inclusion on this list for a second time reflects its sustained momentum and leadership in the industry.

“It is an incredible honor to be recognized by the Zweig Group again this year,” said Rod Zubella, CEO of Vierbicher. “These awards are a testament to our team’s dedication, energy and shared vision. At Vierbicher, we believe that when we invest in our people and culture, excellence follows — for our clients, each other and the communities we serve.”

Vierbicher’s continued success stems from its strong internal culture, emphasis on growth and innovation, and its unwavering focus on delivering high-quality, client-centered solutions. With offices across Wisconsin, the firm remains deeply committed to making a lasting impact through thoughtful planning, design and collaboration.

Badger Football Season Parking Passes Available from RMHC-Madison

If you, your friends, or your company hold season pass tickets for Badger football, and are in search of parking to complement them, look no further! Ronald McDonald House Madison is once again partnering with the McDonald’s on Regent Street to offer Parking with a Purpose.

For just $350 you can reserve a prime parking spot for every home game during the 2025 football season AND help families stay close to their seriously ill children. Learn more by reaching out to Tiyanna Boyd with any questions at tboyd@rmhcmadison.org.